Using Artificial Intelligence to Assess the Teratogenic Risk of Vitamin A Supplements

Area of Science:

• Teratology
• Pharmacovigilance
• Nutritional Science

Background:

• High-dose vitamin A is a known teratogen, causing severe fetal abnormalities.
• Prescription acne medications containing vitamin A derivatives, such as isotretinoin, are strictly regulated (e.g., iPledge program) to prevent fetal exposure.

Discussion:

• Over-the-counter (OTC) vitamin A supplements bypass these stringent regulations.
• Inconsistent labeling and lack of Food and Drug Administration (FDA) oversight complicate accurate vitamin A content determination in OTC supplements.
• Generative AI tools like ChatGPT can assist in calculating vitamin A content if manufacturers provide adequate data.

Key Insights:

• Significant risk of teratogenicity associated with high vitamin A intake, particularly during pregnancy.
• Regulatory gaps exist for OTC vitamin A supplements compared to prescription forms.
• Consumer reliance on AI tools for supplement analysis is hindered by incomplete manufacturer data.

Outlook:

• Need for enhanced FDA regulation and standardized labeling for OTC vitamin A supplements.
• Potential for AI tools to improve consumer understanding of supplement content, contingent on data availability.
• Importance of public health initiatives to educate consumers on the risks of high-dose vitamin A from unregulated sources.